Financhill
Back

Adagio Medical Holdings Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
14

ADGM
Adagio Medical Holdings

Last Price:
2.71
Seasonality Move:
0.79%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Adagio Medical Holdings Price Quote

$2.71

Adagio Medical Holdings Key Stats

Sell
14
Adagio Medical Holdings (ADGM) is a Sell

Day range:
$2.71 - $2.75
52-week range:
$2.40 - $11.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.91%

Volume:
2.5K
Avg. volume:
17.3K
1-year change:
-75.05%
Market cap:
$20.4M
Revenue:
$0
EPS:
$-0.27

How Much Does Adagio Medical Holdings Make?

Data Unavailable

Is Adagio Medical Holdings Growing As A Company?

Data Unavailable

Adagio Medical Holdings Stock Price Performance

What Is Adagio Medical Holdings 52-Week High & Low?

Adagio Medical Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Adagio Medical Holdings?

Is Adagio Medical Holdings Cash Flow Positive?

  • What Is ADGM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1M
  • What Is Adagio Medical Holdings’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.9M
  • What Is Adagio Medical Holdings’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $3M

Adagio Medical Holdings Return On Invested Capital

Data Unavailable

Adagio Medical Holdings Earnings Date & Stock Price

Adagio Medical Holdings Competitors

Adagio Medical Holdings Dividend Yield

Adagio Medical Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many ADGM shares are owned by institutional investors?
    23.1K ADGM shares are owned by institutional investors
  • How many ADGM shares are owned by insiders?
    44.2K ADGM shares are owned by insiders